Compounds > icrf 193
Page last updated: 2024-09-03

icrf 193 and topotecan

icrf 193 has been researched along with topotecan in 1 studies

Compound Research Comparison

Studies
(icrf 193)		Trials
(icrf 193)		Recent Studies (post-2010)
(icrf 193)		Studies
(topotecan)		Trials
(topotecan)		Recent Studies (post-2010) (topotecan)
1550302,392626792

Protein Interaction Comparison

ProteinTaxonomyicrf 193 (IC50)topotecan (IC50)
Cytochrome P450 3A4Homo sapiens (human)1.5211
DNA topoisomerase 1Homo sapiens (human)0.8525
DNA topoisomerase 2-alphaHomo sapiens (human)0.605
DNA topoisomerase 2-betaHomo sapiens (human)0.605
Hypoxia-inducible factor 1-alphaHomo sapiens (human)0.06
Multidrug and toxin extrusion protein 2Homo sapiens (human)8.6
Multidrug and toxin extrusion protein 1Homo sapiens (human)1.3
Broad substrate specificity ATP-binding cassette transporter ABCG2Homo sapiens (human)0.17

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Furue, H1

Reviews

1 review(s) available for icrf 193 and topotecan

ArticleYear
[Topoisomerase inhibitors developing in Japan].
    Gan to kagaku ryoho. Cancer & chemotherapy, 1993, Volume: 20, Issue:1

    Topics: Animals; Antineoplastic Agents; Antineoplastic Agents, Phytogenic; Benzopyrans; Camptothecin; Diketopiperazines; Glycosides; Humans; Irinotecan; Neoplasms; Phenazines; Piperazines; Razoxane; Topotecan

1993